(SMHN) SÜSS MicroTec SE - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000A1K0235
Mask Aligners, Coaters, Developers, Scanners, Bonders
SMHN EPS (Earnings per Share)
SMHN Revenue
Description: SMHN SÜSS MicroTec SE October 22, 2025
SÜSS MicroTec SE (XETRA:SMHN) designs, manufactures and services equipment for microelectronics and MEMS production, operating through two divisions: Advanced Backend Solutions and Photomask Solutions. Its product portfolio includes mask aligners, coaters, developers, UV projection scanners, and bonding systems that serve advanced packaging, compound semiconductors, 3D-IC integration, and photomask cleaning markets. The firm has a global footprint spanning Europe, the Middle East, Africa, North America and the Asia-Pacific, and traces its roots back to 1949 in Garching bei München, Germany.
In FY 2023 the company reported revenue of roughly €1.1 billion and an EBITDA margin near 13%, reflecting strong demand for equipment that enables heterogeneous integration and AI-driven chip designs. R&D spending stayed around €120 million, underscoring its focus on next-generation lithography and bonding technologies. The sector is being propelled by the shift toward 2.5D/3D ICs in data-center, automotive and high-performance computing applications, while supply-chain tightness in photomask production adds a secular tailwind for SÜSS’s specialized cleaning systems.
For a deeper, data-driven valuation framework, you may find the company’s profile on ValueRay worth a look.
SMHN Stock Overview
| Market Cap in USD | 816m |
| Sub-Industry | Semiconductor Materials & Equipment |
| IPO / Inception |
SMHN Stock Ratings
| Growth Rating | 11.0% |
| Fundamental | 76.1% |
| Dividend Rating | 56.3% |
| Return 12m vs S&P 500 | -57.9% |
| Analyst Rating | - |
SMHN Dividends
| Dividend Yield 12m | 1.08% |
| Yield on Cost 5y | 1.88% |
| Annual Growth 5y | 11.80% |
| Payout Consistency | 98.8% |
| Payout Ratio | 9.5% |
SMHN Growth Ratios
| Growth Correlation 3m | 52.5% |
| Growth Correlation 12m | -73.5% |
| Growth Correlation 5y | 65.5% |
| CAGR 5y | 25.29% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.39 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.19 |
| Sharpe Ratio 12m | -1.19 |
| Alpha | -77.19 |
| Beta | 1.791 |
| Volatility | 121.74% |
| Current Volume | 130.8k |
| Average Volume 20d | 130.8k |
| Stop Loss | 25.9 (-7.1%) |
| Signal | 0.09 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (56.7m TTM) > 0 and > 6% of Revenue (6% = 31.2m TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA -9.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 52.02% (prev 61.16%; Δ -9.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -8.11m <= Net Income 56.7m (YES >=105%, WARN >=100%) |
| Net Debt (-43.3m) to EBITDA (97.8m) ratio: -0.44 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.0m) change vs 12m ago -22.28% (target <= -2.0% for YES) |
| Gross Margin 38.57% (prev 36.64%; Δ 1.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 106.3% (prev 81.95%; Δ 24.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 199.0 (EBITDA TTM 97.8m / Interest Expense TTM 451.0k) >= 6 (WARN >= 3) |
Altman Z'' 7.04
| (A) 0.51 = (Total Current Assets 422.5m - Total Current Liabilities 152.1m) / Total Assets 532.9m |
| (B) 0.43 = Retained Earnings (Balance) 228.1m / Total Assets 532.9m |
| (C) 0.18 = EBIT TTM 89.7m / Avg Total Assets 488.9m |
| (D) 1.03 = Book Value of Equity 241.7m / Total Liabilities 235.4m |
| Total Rating: 7.04 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.09
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield -3.58% = -1.79 |
| 3. FCF Margin -4.54% = -1.70 |
| 4. Debt/Equity 0.19 = 2.48 |
| 5. Debt/Ebitda -0.44 = 2.50 |
| 6. ROIC - WACC (= 10.64)% = 12.50 |
| 7. RoE 20.05% = 1.67 |
| 8. Rev. Trend 80.65% = 6.05 |
| 9. EPS Trend 57.52% = 2.88 |
What is the price of SMHN shares?
As of November 01, 2025, the stock is trading at EUR 27.88 with a total of 130,753 shares traded.
Over the past week, the price has changed by -24.20%, over one month by -8.59%, over three months by -12.93% and over the past year by -48.91%.
Over the past week, the price has changed by -24.20%, over one month by -8.59%, over three months by -12.93% and over the past year by -48.91%.
Is SÜSS MicroTec SE a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, SÜSS MicroTec SE (XETRA:SMHN) is currently (November 2025)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 76.09 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMHN is around 26.12 EUR . This means that SMHN is currently overvalued and has a potential downside of -6.31%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMHN is around 26.12 EUR . This means that SMHN is currently overvalued and has a potential downside of -6.31%.
Is SMHN a buy, sell or hold?
SÜSS MicroTec SE has no consensus analysts rating.
What are the forecasts/targets for the SMHN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46 | 65.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 30 | 7.4% |
SMHN Fundamental Data Overview January 01, 1970
Market Cap USD = 816.1m (703.1m EUR * 1.1608 EUR.USD)
Market Cap EUR = 703.1m (703.1m EUR * 1.0 EUR.EUR)
P/E Trailing = 11.7134
P/S = 1.3526
P/B = 2.1435
Beta = 1.791
Revenue TTM = 519.8m EUR
EBIT TTM = 89.7m EUR
EBITDA TTM = 97.8m EUR
Long Term Debt = 3.44m EUR (from longTermDebt, last quarter)
Short Term Debt = 7.26m EUR (from shortTermDebt, last quarter)
Debt = 55.8m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -43.3m EUR (from netDebt column, last quarter)
Enterprise Value = 659.3m EUR (703.1m + Debt 55.8m - CCE 99.6m)
Interest Coverage Ratio = 199.0 (Ebit TTM 89.7m / Interest Expense TTM 451.0k)
FCF Yield = -3.58% (FCF TTM -23.6m / Enterprise Value 659.3m)
FCF Margin = -4.54% (FCF TTM -23.6m / Revenue TTM 519.8m)
Net Margin = 10.92% (Net Income TTM 56.7m / Revenue TTM 519.8m)
Gross Margin = 38.57% ((Revenue TTM 519.8m - Cost of Revenue TTM 319.3m) / Revenue TTM)
Gross Margin QoQ = 36.48% (prev 37.93%)
Tobins Q-Ratio = 1.24 (Enterprise Value 659.3m / Total Assets 532.9m)
Interest Expense / Debt = 0.18% (Interest Expense 100.0k / Debt 55.8m)
Taxrate = 28.27% (6.18m / 21.9m)
NOPAT = 64.4m (EBIT 89.7m * (1 - 28.27%))
Current Ratio = 2.78 (Total Current Assets 422.5m / Total Current Liabilities 152.1m)
Debt / Equity = 0.19 (Debt 55.8m / totalStockholderEquity, last quarter 297.5m)
Debt / EBITDA = -0.44 (Net Debt -43.3m / EBITDA 97.8m)
Debt / FCF = 1.84 (negative FCF - burning cash) (Net Debt -43.3m / FCF TTM -23.6m)
Total Stockholder Equity = 283.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.65% (Net Income 56.7m / Total Assets 532.9m)
RoE = 20.05% (Net Income TTM 56.7m / Total Stockholder Equity 283.0m)
RoCE = 31.32% (EBIT 89.7m / Capital Employed (Equity 283.0m + L.T.Debt 3.44m))
RoIC = 22.33% (NOPAT 64.4m / Invested Capital 288.2m)
WACC = 11.69% (E(703.1m)/V(758.9m) * Re(12.61%) + D(55.8m)/V(758.9m) * Rd(0.18%) * (1-Tc(0.28)))
Discount Rate = 12.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -11.51%
Fair Price DCF = unknown (Cash Flow -23.6m)
EPS Correlation: 57.52 | EPS CAGR: 70.19% | SUE: 0.62 | # QB: 0
Revenue Correlation: 80.65 | Revenue CAGR: 29.43% | SUE: 1.07 | # QB: 1
Market Cap EUR = 703.1m (703.1m EUR * 1.0 EUR.EUR)
P/E Trailing = 11.7134
P/S = 1.3526
P/B = 2.1435
Beta = 1.791
Revenue TTM = 519.8m EUR
EBIT TTM = 89.7m EUR
EBITDA TTM = 97.8m EUR
Long Term Debt = 3.44m EUR (from longTermDebt, last quarter)
Short Term Debt = 7.26m EUR (from shortTermDebt, last quarter)
Debt = 55.8m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -43.3m EUR (from netDebt column, last quarter)
Enterprise Value = 659.3m EUR (703.1m + Debt 55.8m - CCE 99.6m)
Interest Coverage Ratio = 199.0 (Ebit TTM 89.7m / Interest Expense TTM 451.0k)
FCF Yield = -3.58% (FCF TTM -23.6m / Enterprise Value 659.3m)
FCF Margin = -4.54% (FCF TTM -23.6m / Revenue TTM 519.8m)
Net Margin = 10.92% (Net Income TTM 56.7m / Revenue TTM 519.8m)
Gross Margin = 38.57% ((Revenue TTM 519.8m - Cost of Revenue TTM 319.3m) / Revenue TTM)
Gross Margin QoQ = 36.48% (prev 37.93%)
Tobins Q-Ratio = 1.24 (Enterprise Value 659.3m / Total Assets 532.9m)
Interest Expense / Debt = 0.18% (Interest Expense 100.0k / Debt 55.8m)
Taxrate = 28.27% (6.18m / 21.9m)
NOPAT = 64.4m (EBIT 89.7m * (1 - 28.27%))
Current Ratio = 2.78 (Total Current Assets 422.5m / Total Current Liabilities 152.1m)
Debt / Equity = 0.19 (Debt 55.8m / totalStockholderEquity, last quarter 297.5m)
Debt / EBITDA = -0.44 (Net Debt -43.3m / EBITDA 97.8m)
Debt / FCF = 1.84 (negative FCF - burning cash) (Net Debt -43.3m / FCF TTM -23.6m)
Total Stockholder Equity = 283.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.65% (Net Income 56.7m / Total Assets 532.9m)
RoE = 20.05% (Net Income TTM 56.7m / Total Stockholder Equity 283.0m)
RoCE = 31.32% (EBIT 89.7m / Capital Employed (Equity 283.0m + L.T.Debt 3.44m))
RoIC = 22.33% (NOPAT 64.4m / Invested Capital 288.2m)
WACC = 11.69% (E(703.1m)/V(758.9m) * Re(12.61%) + D(55.8m)/V(758.9m) * Rd(0.18%) * (1-Tc(0.28)))
Discount Rate = 12.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -11.51%
Fair Price DCF = unknown (Cash Flow -23.6m)
EPS Correlation: 57.52 | EPS CAGR: 70.19% | SUE: 0.62 | # QB: 0
Revenue Correlation: 80.65 | Revenue CAGR: 29.43% | SUE: 1.07 | # QB: 1